Get the latest news on Hexpol stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on HXPLF performance

Latest Hexpol Stock News | OTC:HXPLF | Benzinga

Hexpol AB manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into two segments based on product type. The compounding segment, which generates the vast majority of revenue, sells synthetic rubber to the automotive, aerospace, footwear, and pharmaceutical industries. The company's synthetic rubber products are used in the production of tires, hoses, seals, footwear, and pharmaceuticals. The engineered products segment sells gaskets used in plate heat exchangers, forklift wheels, and castor wheels. The Americas generates the majority of its revenue from geographic market.

Earnings

News

HXPLF

Hexpol Posts Rise In Q3 Profit

Hexpol AB

Hexpol

&nbsp;

<h2>Upgrades</h2>

<ul>
	<li>Morgan Stanley upgraded the previous rating for Wayfair Inc (NYSE:<a class="ticker" href="/stock/W#NYSE">W</a>) from Underweight to Equal-Weight. Wayfair earned $1.24 in the fourth quarter, compared to $2.80 in the year-ago quarter. The current stock performance of Wayfair shows a 52-week-high of $369.00 and a 52-week-low of $21.70. Moreover, at the end of the last trading period, the closing price was at $258.34.</li>
	<li>Credit Suisse upgraded the previous rating for Elanco Animal Health Inc (NYSE:<a class="ticker" href="/stock/ELAN#NYSE">ELAN</a>) from Neutral to Outperform. For the fourth quarter, Elanco Animal Health had an EPS of $0.12, compared to year-ago quarter EPS of $0.23. The stock has a 52-week-high of $34.09 and a 52-week-low of $15.17. At the end of the last trading period, Elanco Animal Health closed at $31.68.</li>
	<li>According to Pareto, the prior rating for Dorian LPG Ltd (NYSE:<a class="ticker" href="/stock/LPG#NYSE">LPG</a>) was changed from Sell to Hold. In the third quarter, Dorian LPG showed an EPS of $0.70, compared to $0.63 from the year-ago quarter. The stock has a 52-week-high of $14.90 and a 52-week-low of $6.08. At the end of the last trading period, Dorian LPG closed at $13.09.</li>
	<li>Compass Point upgraded the previous rating for Kinsale Capital Group Inc (NASDAQ:<a class="ticker" href="/stock/KNSL#NASDAQ">KNSL</a>) from Neutral to Buy. Kinsale Capital Group earned $1.14 in the fourth quarter, compared to $0.63 in the year-ago quarter. The stock has a 52-week-high of $252.69 and a 52-week-low of $80.93. At the end of the last trading period, Kinsale Capital Group closed at $168.53.</li>
	<li>For Sunnova Energy International Inc (NYSE:<a class="ticker" href="/stock/NOVA#NYSE">NOVA</a>), Credit Suisse upgraded the previous rating of Neutral to Outperform. For the fourth quarter, Sunnova Energy Intl had an EPS of $0.00, compared to year-ago quarter EPS of $0.21. At the moment, the stock has a 52-week-high of $57.70 and a 52-week-low of $6.12. Sunnova Energy Intl closed at $41.83 at the end of the last trading period.</li>
	<li>For HP Inc (NYSE:<a class="ticker" href="/stock/HPQ#NYSE">HPQ</a>), JP Morgan upgraded the previous rating of Neutral to Overweight. In the first quarter, HP showed an EPS of $0.92, compared to $0.65 from the year-ago quarter. The current stock performance of HP shows a 52-week-high of $30.00 and a 52-week-low of $12.54. Moreover, at the end of the last trading period, the closing price was at $28.24.</li>
	<li>According to Morgan Stanley, the prior rating for L Brands Inc (NYSE:<a class="ticker" href="/stock/LB#NYSE">LB</a>) was changed from Equal-Weight to Overweight. For the fourth quarter, L Brands had an EPS of $3.03, compared to year-ago quarter EPS of $1.88. At the moment, the stock has a 52-week-high of $57.19 and a 52-week-low of $8.00. L Brands closed at $52.14 at the end of the last trading period.</li>
	<li>Morgan Stanley upgraded the previous rating for Carvana Co (NYSE:<a class="ticker" href="/stock/CVNA#NYSE">CVNA</a>) from Equal-Weight to Overweight. For the fourth quarter, Carvana had an EPS of $0.40, compared to year-ago quarter EPS of $0.79. The stock has a 52-week-high of $314.56 and a 52-week-low of $22.16. At the end of the last trading period, Carvana closed at $264.00.</li>
	<li>Atlantic Equities upgraded the previous rating for American International Group Inc (NYSE:<a class="ticker" href="/stock/AIG#NYSE">AIG</a>) from Neutral to Overweight. In the fourth quarter, American Intl Gr showed an EPS of $0.94, compared to $1.03 from the year-ago quarter. The stock has a 52-week-high of $46.34 and a 52-week-low of $16.07. At the end of the last trading period, American Intl Gr closed at $43.98.</li>
	<li>RBC Capital upgraded the previous rating for Owl Rock Capital Corp (NYSE:<a class="ticker" href="/stock/ORCC#NYSE">ORCC</a>) from Sector Perform to Outperform. Owl Rock Capital earned $0.29 in the fourth quarter, compared to $0.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $15.55 and a 52-week-low of $8.09. Owl Rock Capital closed at $13.77 at the end of the last trading period.</li>
	<li>For Canfor Pulp Products Inc (OTC:<a class="ticker" href="/stock/CFPUF#OTC">CFPUF</a>), RBC Capital upgraded the previous rating of Sector Perform to Outperform. At the moment, the stock has a 52-week-high of $6.05 and a 52-week-low of $2.87. Canfor Pulp Products closed at $7.32 at the end of the last trading period.</li>
	<li>For LivePerson Inc (NASDAQ:<a class="ticker" href="/stock/LPSN#NASDAQ">LPSN</a>), JP Morgan upgraded the previous rating of Neutral to Overweight. In the fourth quarter, LivePerson showed an EPS of $0.20, compared to $0.43 from the year-ago quarter. The current stock performance of LivePerson shows a 52-week-high of $72.23 and a 52-week-low of $14.08. Moreover, at the end of the last trading period, the closing price was at $58.17.</li>
</ul>

<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>

&nbsp;

<h2>Downgrades</h2>

<ul>
	<li>According to Morgan Stanley, the prior rating for Pandion Therapeutics Inc (NASDAQ:<a class="ticker" href="/stock/PAND#NASDAQ">PAND</a>) was changed from Overweight to Equal-Weight. Interestingly, in the third quarter, Pandion Therapeutics&#39;s EPS was $0.51. At the moment, the stock has a 52-week-high of $60.71 and a 52-week-low of $10.28. Pandion Therapeutics closed at $59.81 at the end of the last trading period.</li>
	<li>Wedbush downgraded the previous rating for Fate Therapeutics Inc (NASDAQ:<a class="ticker" href="/stock/FATE#NASDAQ">FATE</a>) from Outperform to Neutral. In the fourth quarter, Fate Therapeutics showed an EPS of $0.61, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $121.16 and a 52-week-low of $16.75. Fate Therapeutics closed at $86.27 at the end of the last trading period.</li>
	<li>For Waterstone Financial Inc (NASDAQ:<a class="ticker" href="/stock/WSBF#NASDAQ">WSBF</a>), Piper Sandler downgraded the previous rating of Overweight to Neutral. In the fourth quarter, Waterstone Financial showed an EPS of $1.17, compared to $0.34 from the year-ago quarter. The current stock performance of Waterstone Financial shows a 52-week-high of $20.95 and a 52-week-low of $12.10. Moreover, at the end of the last trading period, the closing price was at $20.21.</li>
	<li>For Sage Therapeutics Inc (NASDAQ:<a class="ticker" href="/stock/SAGE#NASDAQ">SAGE</a>), Mizuho downgraded the previous rating of Buy to Neutral. For the fourth quarter, Sage Therapeutics had an EPS of $18.19, compared to year-ago quarter EPS of $3.25. The stock has a 52-week-high of $98.39 and a 52-week-low of $25.01. At the end of the last trading period, Sage Therapeutics closed at $83.45.</li>
	<li>According to JP Morgan, the prior rating for SLR Investment Corp (NASDAQ:<a class="ticker" href="/stock/SLRC#NASDAQ">SLRC</a>) was changed from Overweight to Neutral. SLR Investment earned $0.35 in the fourth quarter, compared to $0.41 in the year-ago quarter. The stock has a 52-week-high of $20.04 and a 52-week-low of $7.42. At the end of the last trading period, SLR Investment closed at $19.14.</li>
	<li>Stifel downgraded the previous rating for World Fuel Services Corp (NYSE:<a class="ticker" href="/stock/INT#NYSE">INT</a>) from Buy to Hold. In the fourth quarter, World Fuel Services showed an EPS of $0.02, compared to $0.87 from the year-ago quarter. The current stock performance of World Fuel Services shows a 52-week-high of $36.76 and a 52-week-low of $18.36. Moreover, at the end of the last trading period, the closing price was at $35.02.</li>
	<li>For WNS (Holdings) Ltd (NYSE:<a class="ticker" href="/stock/WNS#NYSE">WNS</a>), Baird downgraded the previous rating of Outperform to Neutral. In the third quarter, WNS (Hldgs) showed an EPS of $0.79, compared to $0.80 from the year-ago quarter. At the moment, the stock has a 52-week-high of $78.07 and a 52-week-low of $34.26. WNS (Hldgs) closed at $76.90 at the end of the last trading period.</li>
	<li>For Fly Leasing Ltd (NYSE:<a class="ticker" href="/stock/FLY#NYSE">FLY</a>), Deutsche Bank downgraded the previous rating of Buy to Hold. Fly Leasing earned $0.01 in the fourth quarter, compared to $2.49 in the year-ago quarter. At the moment, the stock has a 52-week-high of $17.99 and a 52-week-low of $3.41. Fly Leasing closed at $12.59 at the end of the last trading period.</li>
	<li>According to Morgan Stanley, the prior rating for Verra Mobility Corp (NASDAQ:<a class="ticker" href="/stock/VRRM#NASDAQ">VRRM</a>) was changed from Overweight to Equal-Weight. Verra Mobility earned $0.04 in the third quarter, compared to $0.11 in the year-ago quarter. At the moment, the stock has a 52-week-high of $17.07 and a 52-week-low of $5.63. Verra Mobility closed at $14.12 at the end of the last trading period.</li>
	<li>For Agios Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="/stock/AGIO#NASDAQ">AGIO</a>), SVB Leerink downgraded the previous rating of Outperform to Market Perform. In the fourth quarter, Agios Pharmaceuticals showed an EPS of $1.41, compared to $1.60 from the year-ago quarter. The stock has a 52-week-high of $58.93 and a 52-week-low of $27.77. At the end of the last trading period, Agios Pharmaceuticals closed at $50.29.</li>
	<li>For Voyager Therapeutics Inc (NASDAQ:<a class="ticker" href="/stock/VYGR#NASDAQ">VYGR</a>), Baird downgraded the previous rating of Outperform to Neutral. For the fourth quarter, Voyager Therapeutics had an EPS of $0.43, compared to year-ago quarter EPS of $0.34. The current stock performance of Voyager Therapeutics shows a 52-week-high of $14.62 and a 52-week-low of $6.16. Moreover, at the end of the last trading period, the closing price was at $6.23.</li>
	<li>Raymond James downgraded the previous rating for Best Buy Co Inc (NYSE:<a class="ticker" href="/stock/BBY#NYSE">BBY</a>) from Strong Buy to Outperform. Best Buy Co earned $3.48 in the fourth quarter, compared to $2.90 in the year-ago quarter. The stock has a 52-week-high of $124.89 and a 52-week-low of $48.10. At the end of the last trading period, Best Buy Co closed at $102.87.</li>
	<li>For Pandion Therapeutics Inc (NASDAQ:<a class="ticker" href="/stock/PAND#NASDAQ">PAND</a>), SVB Leerink downgraded the previous rating of Outperform to Market Perform. In the third quarter, Pandion Therapeutics earned $0.51. The current stock performance of Pandion Therapeutics shows a 52-week-high of $60.71 and a 52-week-low of $10.28. Moreover, at the end of the last trading period, the closing price was at $59.81.</li>
</ul>

<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>

&nbsp;

<h2>Initiations</h2>

<ul>
	<li>Roth Capital initiated coverage on Amyris Inc (NASDAQ:<a class="ticker" href="/stock/AMRS#NASDAQ">AMRS</a>) with a Buy rating. The price target for Amyris is set to $20.00. For the third quarter, Amyris had an EPS of $0.18, compared to year-ago quarter EPS of $0.45. The current stock performance of Amyris shows a 52-week-high of $18.57 and a 52-week-low of $1.40. Moreover, at the end of the last trading period, the closing price was at $13.82.</li>
	<li>Rosenblatt initiated coverage on Elastic NV (NYSE:<a class="ticker" href="/stock/ESTC#NYSE">ESTC</a>) with a Buy rating. The price target for Elastic is set to $175.00. In the third quarter, Elastic showed an EPS of $0.04, compared to $0.28 from the year-ago quarter. The current stock performance of Elastic shows a 52-week-high of $176.49 and a 52-week-low of $39.01. Moreover, at the end of the last trading period, the closing price was at $131.54.</li>
	<li>With an Outperform rating, Oppenheimer initiated coverage on icad Inc (NASDAQ:<a class="ticker" href="/stock/ICAD#NASDAQ">ICAD</a>). The price target seems to have been set at $27.00 for icad. In the fourth quarter, icad showed an EPS of $0.06, compared to $0.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.88 and a 52-week-low of $5.91. icad closed at $17.19 at the end of the last trading period.</li>
	<li>Deutsche Bank initiated coverage on Sika AG (OTC:<a class="ticker" href="/stock/SXYAY#OTC">SXYAY</a>) with a Buy rating. The current stock performance of Sika shows a 52-week-high of $27.26 and a 52-week-low of $13.76. Moreover, at the end of the last trading period, the closing price was at $26.98.</li>
</ul>

<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Upgrades

Downgrades

Initiation

Intraday Update

Analyst Ratings

AGIO

AMRS

BRLXF

CEQP

CFPUF

CVNA

ELAN

ESTC

FATE

GBERY

GMVHF

ICAD

KGSPY

KNSL

KRNTY

LPSN

NOVA

ORCC

PAND

SAGE

SDVKY

SLRC

SUNS

SXYAY

TCPC

VRRM

VYGR

WSBF

Benzinga's Top Ratings Upgrades, Downgrades For February 26, 2021

Berenberg analyst Fabian Weinstock initiates coverage on Hexpol (OTC:<a class="ticker" href="/stock/HXPLF#OTC">HXPLF</a>) with a Sell rating.

Berenberg Initiates Coverage On Hexpol with Sell Rating

Hexpol AB (OTC: <a class="ticker" href="/stock/hxplf#OTC">HXPLF</a>) reported an increase in its third-quarter net profit.

Hexpol's quarterly net profit rose to 192 million kronor ($29.2 million), from SEK165 million, in the year-ago period. 

Its sales gained 7% y/y to SEK1.98 billion, while operating profit rose to SEK280 million, from SEK235 million.

Comments

Hexpol Stock News

News

Latest Hexpol Stock News | OTC:HXPLF | Benzinga

Friday, February 26, 2021

Tuesday, October 23, 2012

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga